Macie Enman, MD | |
6655 S Cimarron Rd Ste 100, Las Vegas, NV 89113-2181 | |
(205) 934-9600 | |
Not Available |
Full Name | Macie Enman |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 6655 S Cimarron Rd Ste 100, Las Vegas, Nevada |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629530787 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | MD.43818 (Alabama) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Macie Enman, MD 6655 S Cimarron Rd Ste 100, Las Vegas, NV 89113-2181 Ph: () - | Macie Enman, MD 6655 S Cimarron Rd Ste 100, Las Vegas, NV 89113-2181 Ph: (205) 934-9600 |
News Archive
A computer program trained to see patterns among thousands of breast ultrasound images can aid physicians in accurately diagnosing breast cancer, a new study shows.
Regular exercise protects patients from heart disease whereas conditions such as high blood pressure can lead to heart failure and Atrial Fibrillation, the most common type of irregular heartbeat.
Nanotherapeutics, Inc., announced that it has filed an Investigational New Drug (IND) Application with the Food and Drug Administration (FDA) for NanoDTPA™ an orally administered capsule that is a less invasive treatment alternative to the FDA approved injectable Zn-DTPA (diethylenetriamine pentacetic acid). DTPA is used to remove radioactive compounds from the body to help eliminate the contamination. The NanoDTPA™ capsule is a unique orally-bioavailable fine particle formulation that allows DTPA to be absorbed into the body from the gastrointestinal tract.
Research by Keck Medicine of USC ophthalmology scientists demonstrates that African Americans bear heavier burden of diabetic macular edema (DME), one of the leading causes of blindness in diabetic patients in the United States.
Readmission to a hospital after standard surgical treatment for colon cancer is far more common than suspected for elderly patients according to researchers who presented their findings at the 2009 Clinical Congress of the American College of Surgeons. Results from the first study to determine nationwide readmission rates following colectomy [surgical removal of malignant disease and part of the colon] in the Medicare population revealed that nearly one in nine patients over the age of 65 was readmitted within 30 days.
› Verified 6 days ago